Pancreatic cancer gene study aims to personalize care

NCT ID NCT02869802

Recruiting now Knowledge-focused Sponsor: British Columbia Cancer Agency Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at genetic changes in metastatic pancreatic cancer to see if they can help guide treatment choices. Researchers will take tumor biopsies and blood samples from 190 patients starting chemotherapy. The main goal is to see if genetic test results can be returned within 8 weeks, which could make this approach practical for future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose better treatments for pancreatic cancer patients based on their tumor's genetic profile.
What could go wrong: This is an early feasibility study, not a treatment trial. It may not lead to immediate improvements, and genetic testing might not always be useful for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer malignant pancreatic neoplasm neoplasm pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER PANCREATIC CANCER

Contacts and locations

Locations

BC Cancer - Vancouver
RECRUITING

Vancouver, British Columbia, V5Z 4E6, Canada
Cross Cancer Institute
WITHDRAWN

Edmonton, Alberta, T6G 1Z2, Canada
The Ottawa Hospital
ACTIVE_NOT_RECRUITING

Ottawa, Ontario, K1H 8L6, Canada
Tom Baker Cancer Centre
RECRUITING

Calgary, Alberta, T2N 4N2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.